Company News

Position: Home >> News >> Company News

Exhibition Review | Shanghai Jinxin Presents at the 68th CIPM in Xiamen

Time:2026-11-02    Resource:Admin    visits:1

The grand event the 68th CIPM in Xiamen has come to a successful conclusion! The 68th National Pharmaceutical Machinery Exposition & China International Pharmaceutical Machinery Exposition wrapped up smoothly at Xiamen International Expo Center. Shanghai Jinxin Pharmaceutical Equipment Engineering Co., Ltd. showcased core biological fermentation equipment, intelligent automatic control systems and one-stop GMP engineering solutions. We held in-depth exchanges with industrial peers from biomedicine, synthetic biology, API, and traditional Chinese medicine fermentation sectors to explore paths for process industrialization.

As a Shanghai Specialized, Refined, Differential and Innovative High-tech Enterprise, Jinxin specializes in complete biological pharmaceutical equipment and EPC general contracting services. We provide a full spectrum of services including lab/pilot/industrial-scale fermenters, disc/tubular centrifuges, sterile liquid preparation systems, CIP/SIP automatic control units, utility support systems and modular whole-plant design & construction. All equipment complies strictly with GMP, FDA and CE standards, suitable for scale-up of strain cultivation, collagen, probiotics, plant cell and yeast fermentation processes.

During the exhibition, many new and existing clients visited our booth to inquire about process scale-up, equipment selection, validation delivery and general contracting projects. Our technical team shared practical experience in fermentation scale-up, automatic control and compliance validation on-site to address customer pain points, receiving plenty of inquiries and recognition.

Grateful to every partner who came for communication! The exhibition has ended, yet our service continues. With reliable equipment and mature engineering delivery capability, Shanghai Jinxin keeps supporting pharmaceutical enterprises in smooth transition from lab R&D to large-scale commercial production. We look forward to further follow-up communication, to jointly build compliant, efficient and intelligent biopharmaceutical production lines!

image.png



Prev:Shanghai Jin Xin makes a perfect debut at BioFerm 2026 Hangzhou

Next:没有了!